Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Reprod Sci ; 22(1): 124-31, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24807378

ABSTRACT

We aimed to evaluate whether nerve fibers are present in the endometrial layer of patients submitted to office hysteroscopy and their potential contribution to the pathogenesis of pain during that procedure. Through a prospective case-control study performed in tertiary centers for women's health, endometrium samples were collected during operative office hysteroscopy from 198 cycling women who previously underwent laparoscopy and/or magnetic resonance imaging investigation for infertility assessment. Samples were classified according to the degree of the pain patients experienced and scored from values ranging from 0 (absence of discomfort/pain) to 10 (intolerable pain) on a 10-cm visual analog scale (VAS). The presence of nerve fiber markers (S100, NSE, SP, VIP, NPY, NKA, NKB, NKR1, NKR2, and NKR3) in the endometrium was also evaluated by morphologic and immunohistochemical analyses. We found that S-100, NSE, NKR1, NK-A, NK-B, VIP, and NPY, were immunolocalized in samples of endometrium, in significantly (P < .01, for all) higher levels in samples collected from patients with VAS score > 5 (group A) than ≤ 5 (group B) and significantly (P < .0001 for all) positively correlated with VAS levels. A statistically significant (P = .018) higher prevalence of endometriosis and/or adenomyosis was depicted in patients of group A than group B. Data from the present study led us to conclude that nerve fibers are expressed at the level of the functional layer of the endometrium and may contribute to pain generation during office hysteroscopy, mainly in women affected by endometriosis and adenomyosis.


Subject(s)
Adenomyosis/pathology , Ambulatory Care , Biopsy/adverse effects , Endometriosis/pathology , Endometrium/innervation , Hysteroscopy/adverse effects , Pain/etiology , Adenomyosis/physiopathology , Adult , Case-Control Studies , Endometriosis/physiopathology , Endometrium/pathology , Endometrium/surgery , Female , Humans , Immunohistochemistry , Italy , Middle Aged , Nerve Fibers/chemistry , Neuropeptides/analysis , Pain/diagnosis , Pain/physiopathology , Pain Measurement , Prospective Studies , Tertiary Care Centers
2.
Int J Gynaecol Obstet ; 120(1): 78-81, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23083494

ABSTRACT

OBJECTIVE: To evaluate whether Baby-guard-a new medical device with an ergonomic 3-chamber inflatable abdominal belt-can reduce complications associated with vaginal delivery. METHODS: A randomized controlled single-blind prospective study of 80 pregnant women delivering at term was conducted at San Giuseppe Hospital, Empoli, Italy. In the study group (n=40), the abdominal belt was inflated to optimal therapeutic pressures. In the control group (n=40), the abdominal belt was inflated to minimal, non-therapeutic pressures. Factors relating to maternal, fetal, and labor complications during vaginal delivery were evaluated. RESULTS: Compared with the control group, women in the study group experienced a lower incidence of perineal and cervical lacerations (P<0.001); reduced use of the Kristeller maneuver (P<0.001); shorter duration of the second stage of labor (P<0.001); less psychologic and physical fatigue (P<0.001); fewer maternal requests for cesarean delivery during labor (P<0.001); fewer vacuum extractions (P<0.01); and fewer cesarean deliveries (P<0.02). No neonatal intensive care unit admissions were recorded in the study group versus 7 in the control group (P<0.012). CONCLUSION: Use of the ergonomic 3-chamber inflatable abdominal belt system reduced the incidence of risks associated with vaginal labor. Clinical trials.gov identifier: NCT01566331.


Subject(s)
Cervix Uteri/injuries , Delivery, Obstetric/methods , Fatigue/epidemiology , Perineum/injuries , Adult , Cesarean Section/statistics & numerical data , Delivery, Obstetric/instrumentation , Equipment Design , Ergonomics , Female , Humans , Incidence , Infant, Newborn , Italy , Labor Stage, Second , Lacerations/epidemiology , Pregnancy , Pressure , Prospective Studies , Single-Blind Method , Vacuum Extraction, Obstetrical/statistics & numerical data
3.
Reprod Sci ; 20(7): 755-61, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23232966

ABSTRACT

We did a double-blind, randomized, placebo-controlled study to assess the incidence of infectious complications and the protective effect of antibiotic administration during operative hysteroscopic procedures in an office setting. A total of 1046 consecutively enrolled women with intrauterine lesions were randomly allocated to the reference group (523 patients administered with 1 g of cefazolin intramuscularly) and the study group (523 patients administered with 10 mL of isotonic sodium chloride solution), and treated in office setting by operative hysteroscopy for endometrial polypectomy, uterine septa, submucosal myomas, and intrauterine adhesions. The primary outcome measure was the computation of difference between groups in postsurgical infectious complications occurring in the 5 days after the procedures. The time spent in performing the various procedures did not differ significantly (P > .05) between the groups. With respect to the overall rate of postsurgical infection, we found that 12 (1.15%) of 1046 patients referred with symptoms related to infective complications, 7 (1.3% of 523 women) in the study--untreated--group and 5 (1.0% of 523 women) in the reference group. Such incidences did not differ significantly between the groups (P > .05). Antibiotics were prescribed in all cases of postsurgical infection and the infective process resolved in few days. None of these patients developed serious infections with adnexal involvement, as confirmed by clinical and ultrasounds evaluation. The results of the current study would support the American College of Obstetricians and Gynecologists recommendation not to prescribe routine antibiotic administration in the case of hysteroscopic surgery.


Subject(s)
Ambulatory Surgical Procedures/standards , Anti-Bacterial Agents/administration & dosage , Hysteroscopy/standards , Practice Guidelines as Topic/standards , Adult , Ambulatory Surgical Procedures/methods , Double-Blind Method , Female , Humans , Hysteroscopy/methods , Prospective Studies , Surgical Wound Infection/diagnosis , Surgical Wound Infection/prevention & control
4.
Curr Opin Obstet Gynecol ; 24(3): 180-6, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22395067

ABSTRACT

PURPOSE OF REVIEW: To review the treatments of the cesarean-induced isthmocele in restoring infertility, associated techniques, and the risks of complications associated with their use. RECENT FINDINGS: Isthmocele is a reservoir-like pouch defect on the anterior wall of the uterine isthmus located at the site of a previous cesarean delivery scar. The flow of menstrual blood through the cervix may be slowed by the presence of isthmocele, as the blood may accumulate in the niche because of the presence of fibrotic tissue, causing pelvic pain in the suprapubic area. Moreover, persistence of the menstrual blood after menstruation in the cervix may negatively influence the mucus quality and sperm quality, obstruct sperm transport through the cervical canal, interfere with embryo implantation, leading to secondary infertility. The removal of the local inflamed tissue may be performed by laparoscopic, combined laparoscopic-vaginal, or vaginal surgery, and operative hysteroscopy, a minimally invasive approach to improve symptoms and restore fertility. SUMMARY: Isthmocele occurs after cesarean section, a common method of delivery and one of the most frequent surgical procedures, so that its upward incidence appears likely to continue in the near future. Because of its minimal invasiveness, resectoscopy may be the better choice for treatment, yielding good therapeutic results.


Subject(s)
Cesarean Section/adverse effects , Hysteroscopy , Infertility, Female/surgery , Uterus/surgery , Cicatrix/etiology , Cicatrix/surgery , Female , Humans , Infertility, Female/etiology , Uterus/pathology
5.
Steroids ; 77(5): 528-33, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22342469

ABSTRACT

This randomized, double blind, placebo-controlled study compared the usefulness of danazol 400mg vaginally versus 600mg orally in women as a preoperative preparation for hysteroscopic surgery. Ninety-one fertile women were randomly allocated to Group A (46 patients received 400mg of danazol placed into the posterior vaginal fornix and three oral tablets of commercially available folic acid as a placebo), and Group B [45 women treated with 600mg of danazol orally (200mg three times daily) and two vaginal tablets of Lactobacillus rhamnosus as a placebo]. The patients underwent an operative hysteroscopy, transvaginal sonography, blood tests, and a histological assay. A visual analog scale (VAS) score to compute the degree of the surgeon's satisfaction was used. The outcome measures were as follows: an evaluation of the changes in the endometrial thickness, the prevalence of endometrial atrophy, changes in the blood tests, any collateral effects, the degree of difficulty and view, the duration of the surgical procedure, any complications during the operative hysteroscopy and associated side effects, and the surgeon's satisfaction with the endometrial preparation. The vaginal administration route was associated with a more pronounced effect on the endometrial thickness. Significantly more patients receiving vaginal danazol (45/46) had a hypotrophic endometrium than those receiving oral danazol (37/45, P<0.01). In addition, the patients receiving danazol vaginally had a shorter operating time, lower infusion volume, fewer side effects, and a higher surgeon satisfaction. Vaginal danazol adequately prepares the endometrium for an operative hysteroscopy by thinning the endometrium effectively with few side effects and little impact on the metabolic parameters.


Subject(s)
Danazol/therapeutic use , Estrogen Antagonists/therapeutic use , Hysteroscopy/methods , Preoperative Care/methods , Administration, Intravaginal , Administration, Oral , Adult , Danazol/administration & dosage , Double-Blind Method , Drug Administration Schedule , Endometrium/drug effects , Endometrium/pathology , Endometrium/surgery , Estrogen Antagonists/administration & dosage , Female , Humans , Middle Aged , Treatment Outcome
6.
J Minim Invasive Gynecol ; 19(1): 107-12, 2012.
Article in English | MEDLINE | ID: mdl-22070928

ABSTRACT

STUDY OBJECTIVE: To estimate the efficacy and tolerability of low dose spinal anesthesia during operative hysteroscopy in a group of patients with high surgical risks. DESIGN: Case series study (Canadian Task Force Classification II-2). SETTING: Tertiary centers for women health care. PATIENTS: A total of 47 women affected by endometrial polyps (n = 32), myomas (n = 8), and abnormal uterine bleeding (n = 7) scheduled for inpatient operative hysteroscopy. INTERVENTIONS: Transvaginal ultrasonography; office diagnostic hysteroscopy; preoperative evaluation of American Society of Anesthesiologist (ASA) classification; inpatient operative hysteroscopy; low-dose spinal anesthesia with hyperbaric bupivacaine; compilation of a questionnaire. MAIN OUTCOME MEASURES: Practicability and patients' subjective experiences with spinal anesthesia; duration of cervical dilation and for operative hysteroscopy; infusion volume needed; incidence of surgical complications. RESULTS: Resectoscopy was performed in all patients, with the exception of 1 woman (2.1%) in which spinal anesthesia was unsuccessful. No statistically significant differences were noted among groups in terms of intra- and peri-operative findings. Sensory block induced by spinal anesthesia was suitable for surgery in all patients, and side effects occurred far less frequently than mentioned in the literature. Data reported in the questionnaire revealed that 93.5% of women would choose a spinal anesthesia again for a potential operative hysteroscopy in the future, since for 89.1% of them long lasting anesthesia is of relevance. CONCLUSIONS: Low-dose spinal anesthesia is a feasible technique in the inpatient setting for operative hysteroscopy in women with high surgical risks.


Subject(s)
Adjuvants, Anesthesia/administration & dosage , Anesthesia, Spinal , Anesthetics, Local/administration & dosage , Bupivacaine/administration & dosage , Fentanyl/administration & dosage , Hysteroscopy , Adult , Female , Humans , Leiomyoma/surgery , Middle Aged , Patient Satisfaction , Polyps/surgery , Prospective Studies , Surveys and Questionnaires , Uterine Hemorrhage/surgery , Uterine Neoplasms/surgery
7.
Gynecol Endocrinol ; 27(6): 434-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21204608

ABSTRACT

In a retrospective case-control study, we compared the effectiveness of hysteroscopic correction and hormonal treatment to improve symptoms [postmestrual abnormal uterine bleeding (PAUB), pelvic pain localized in suprapubic site] associated with isthmocele. Women (n = 39; mean age ± SD, 35 ± 4.1 years) were subdivided in Group A [patients (n = 19) subjected to hysteroscopic surgery (isthmoplasty)] and, Group B [women (n = 20) undergoing hormonal treatment consisting of one oral tablet containing 0.075 mg of Gestodene and 0.030 mg of Ethynylestradiol for 21 days, followed by 7 days of suspension]. Resolution and/or improvement of menstrual disorders; patients degree of satisfaction with the treatment were measured 3 months later, by office hysteroscopy (Grop A) or phone call. PAUB and pelvic pain resolution was achieved in all patients: Group A had significant lower numbers of days of menstrual bleeding (P < 0.001), prevalence of pelvic pain in the suprapubic area (P = 0.04) and, higher degree of satisfaction (P < 0.001) compared to Group B. In conclusion, resectoscopic surgery is a valid way to treat patients with symptoms of prolonged postmenstrual uterine bleeding caused by isthmocele. Data from this study also indicate that resectoscopy may be the first choice because it is minimally invasive and yields good therapeutic results.


Subject(s)
Hormones/therapeutic use , Hysteroscopy , Menstruation Disturbances/drug therapy , Menstruation Disturbances/etiology , Menstruation Disturbances/surgery , Uterine Diseases/complications , Adult , Case-Control Studies , Drug Combinations , Ethinyl Estradiol/administration & dosage , Ethinyl Estradiol/therapeutic use , Female , Humans , Norpregnenes/administration & dosage , Norpregnenes/therapeutic use , Progestins/administration & dosage , Progestins/therapeutic use , Retrospective Studies , Uterine Diseases/drug therapy , Uterine Diseases/surgery
8.
J Surg Oncol ; 102(6): 663-70, 2010 Nov 01.
Article in English | MEDLINE | ID: mdl-20721959

ABSTRACT

OBJECTIVES: To analyze the outcomes of cytoreductive surgery and HIPEC in patients with peritoneal carcinomatosis from ovarian cancer. METHODS: Fifty-three patients with peritoneal carcinomatosis from primary (45 cases) and recurrent (8 cases) ovarian cancer were previously treated by systemic chemotherapy with platinum and taxanes and then submitted to surgical cytoreduction and HIPEC (cisplatin and mitomycin-C) with a closed abdomen technique. The median follow-up period was 27 months (range: 3-107). RESULTS: At the end of operation a complete cytoreduction (CCR-0) was obtained in 37 patients (70%). Major morbidity occurred in 12 patients (23%); reoperation was necessary in 2 patients (4%), and no postoperative mortality was observed. Overall 5-year survival probability was 55%; it was 71% in CCR-0, 44% in CCR-1, and none in patients with CCR-2 or CCR-3 residual tumor (log-rank test: P = 0.017). The cumulative risk of recurrence in 37 CCR-0 cases was 54% at 5 years from operation. CONCLUSIONS: The results of our study indicate the feasibility and the potential benefit of a protocol including systemic chemotherapy, surgical cytoreduction and HIPEC in patients with peritoneal carcinomatosis from ovarian cancer. A phase III trial to compare this approach with conventional treatment is needed.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinoma/drug therapy , Carcinoma/secondary , Ovarian Neoplasms/pathology , Peritoneal Neoplasms/drug therapy , Peritoneal Neoplasms/secondary , Adult , Aged , Carcinoma/surgery , Chemotherapy, Cancer, Regional Perfusion , Combined Modality Therapy , Female , Humans , Hyperthermia, Induced , Injections, Intraperitoneal , Middle Aged , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/surgery , Peritoneal Neoplasms/surgery , Recurrence , Treatment Outcome
9.
Fertil Steril ; 94(6): 2319-22, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20079897

ABSTRACT

OBJECTIVE: To compare two distension media, carbon dioxide (CO2) and saline, with regards to patient discomfort and the adequacy of the panoramic view in diagnostic hysteroscopy by the vaginoscopic approach. DESIGN: Randomized prospective study. SETTING: Tertiary referral centers for gynecologic care. PATIENT(S): 264 patients randomly allocated to two groups: CO2 (132 women) and normal saline (132 women). INTERVENTION(S): Office hysteroscopy performed with a forward-oblique 30° telescope (total diameter 5.1 mm) and CO2 as the distension medium or with a forward-oblique 30° telescope (final diameter 5.1mm) and saline solution as the distension medium. MAIN OUTCOME MEASURE(S): Global operative time, pain experienced by patients using a visual analogue scale (VAS), severity of the pain (VAS), incidence of collateral effects (shoulder-tip pain, nausea, or dizziness), degree of difficulty, and view (VAS). RESULT(S): Pelvic discomfort was comparable between groups, without statistically significant differences in intensity or degree of difficulty. However, the visual quality was statistically significantly higher when hysteroscopy was performed with CO2 as the distension medium. CONCLUSION(S): No relevant difference in pain or technical difficulty was found between the two distension media, but CO2 was associated with better quality visualization.


Subject(s)
Carbon Dioxide , Dilatation/methods , Hysteroscopy/methods , Sodium Chloride , Adult , Aged , Ambulatory Surgical Procedures/methods , Dilatation/adverse effects , Female , Humans , Hysteroscopy/adverse effects , Middle Aged , Pain, Postoperative/epidemiology , Uterine Diseases/diagnosis , Uterine Diseases/epidemiology , Young Adult
10.
Fertil Steril ; 94(5): 1882-6, 2010 Oct.
Article in English | MEDLINE | ID: mdl-19819439

ABSTRACT

OBJECTIVE: To compare the effectiveness and safety of harmonic scalpel versus electrosurgery to reduce blood loss during laparoscopic myomectomy. DESIGN: Prospective randomized controlled study. SETTING: Tertiary referral centers for gynecological care. PATIENT(S): One hundred sixty consecutive premenopausal women with symptomatic uterine leiomyomata who were assigned to one of the two treatment groups (a total of 80 patients in each group): treatment with electrosurgery devices with a vasoconstrictive solution (50 mL of saline solution and 0.5 mL of epinephrine [1/2 vial of 1 mg/mL]; group A) or harmonic scalpel (group B). INTERVENTION(S): Laparoscopic myomectomy. MAIN OUTCOMES MEASURE(S): The global operative time, the time spent for myoma enucleation and for suturing uterine wall defects, and intraoperative blood loss as well as the surgical difficulty degree and postoperative pain at 24 and 48 hours after the laparoscopic procedure. RESULT(S): No relevant intra- or postoperative complications were observed in either group. The degree of pain 24 hours after surgery was significantly lower in patients in whom the harmonic scalpel was used. The degree of surgical difficulty did not differ between groups, but the global operative time was significantly shorter in the harmonic scalpel group. CONCLUSION(S): The use of the harmonic scalpel for laparoscopic myomectomy is associated with low total operative time, low intraoperative blood loss, and low postoperative pain, with no increase in surgical difficulty.


Subject(s)
Electrosurgery/methods , Gynecologic Surgical Procedures/methods , Laparoscopy/methods , Laser Therapy/methods , Leiomyoma/surgery , Uterine Neoplasms/surgery , Adult , Blood Loss, Surgical , Electrosurgery/adverse effects , Female , Gynecologic Surgical Procedures/adverse effects , Humans , Laparoscopy/adverse effects , Laser Therapy/adverse effects , Postoperative Hemorrhage , Prospective Studies , Time Factors , Treatment Outcome
11.
In Vivo ; 23(2): 317-21, 2009.
Article in English | MEDLINE | ID: mdl-19414421

ABSTRACT

Intraperitoneal (IP) chemotherapy has been used in patients presenting different stages of ovarian cancer. We performed a critical review of the available literature on IP as first-line treatment in advanced ovarian cancer to consider if this new option should be incorporated into the commonly applied guidelines for treatment of ovarian cancer. We concluded that without further data, it would not be ethically correct to administer chemotherapy intraperitoneally. Outside of planned clinical trials, patients should not be exposed to this treatment modality and its associated toxicity. The present international guidelines are still valid and recommended chemotherapy in advanced ovarian cancer remains treatment with paclitaxel and carboplatin. Further studies on this topic are, however, warranted.


Subject(s)
Antineoplastic Agents/administration & dosage , Infusions, Parenteral/methods , Ovarian Neoplasms/drug therapy , Antineoplastic Agents/toxicity , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Clinical Trials as Topic , Disease Progression , Female , Humans , Infusions, Intravenous , Medical Oncology/methods , Medical Oncology/trends , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...